Media
Media

Carvana’s record quarterly results top Wall Street expectations

Carvana's first-quarter results easily topped Wall Street's expectations as the company reported record sales. ​Read More

Read More
Media

Disney shares surge on earnings beat and many more positive things to like

Disney's quarterly results topped expectations, but the entertainment giant provided plenty more for investors to like. ​Read More

Read More
Media

AMD CEO Lisa Su calls China a ‘large opportunity’ and warns against strict U.S. chip controls

"There should be a balance between export controls for national security as well as ensuring that we get the widest possible adoption," she said. ​Read More

Read More
Media

Uber misses revenue expectations with trips up 18% over last year

CEO Dara Khosrowshahi said that autonomous vehicle tech is "the single greatest opportunity ahead for Uber." ​Read More

Read More
Media

Novo Nordisk shares jump 5% as drugmaker sees copycat Wegovy sales easing in 2025

Novo Nordisk on Wednesday reported a better-than-expected rise in net profit but lowered its full-year sales growth forecast. ​Read More

Read More
Media

Trump tariffs and export curbs on China cast a cloud over major chip stocks

Chip companies from AMD to Super Micro said U.S. tariff policy and export restrictions to China have caused uncertainty for their businesses. ​Read More

Read More
Media

Here’s what to expect when Disney reports earnings before the bell

Disney will report its fiscal second-quarter earnings before the bell on Wednesday. ​Read More

Read More
Media

EA issues strong bookings guidance as CEO touts ‘Battlefield’ reveal

Electronic Arts beat fiscal fourth-quarter bookings estimates. ​Read More

Read More
Media

Super Micro issues weak guidance, cites ‘economic uncertainty and tariff impacts’

A week after issuing disappointing preliminary results, Super Micro said in its earnings release that it could see an impact from President Trump's tariffs. ​Read More

Read More
Media

AstraZeneca unveils new facility as part of multibillion-dollar investment in US manufacturing

AstraZeneca, as part of its ongoing $3.5 billion investment in American innovation, opened its first U.S.-operated cell therapy manufacturing facility in Maryland to help treat cancer patients. The U.K-based pharmaceutical giant said the new $300 million facility in Rockville symbolizes its confidence in America’s role as a “global leader in science, manufacturing and economic growth.”

Read More
This material is for informational purposes is not intended to be relied upon as a forecast, research or investment advice, and is not a recommendation, offer or solicitation to buy or sell any securities or to adopt any investment strategy. The opinions expressed are as of date of publication and are subject to change. Reliance upon information in this material is at the sole discretion of the reader. Past performance is not indicative of current or future results. This information provided is neither tax nor legal advice and investors should consult with their own advisors before making investment decisions. Investment involves risk including possible loss of principal.